COVID-19 Impact on Global Cell-based Assays Market Size, Status and Forecast 2020-2026

September 2020 | 158 pages | ID: CBE73D5DD122EN
QYResearch

Abstracts

This report focuses on the global Cell-based Assays status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell-based Assays development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• BD Medical (US)
• Danaher (US)
• Thermo Fisher Scientific (US)
• General Healthcare (UK)
• Merck KGaA (Germany)
• Perkinelmer (US)
• Charles River Laboratories (US)
• Life Technologies (US)
• Lonza Group (Switzerland)
• Cell Signaling Technology (US)
• Promega (US)
• Cisbio Bioassays (France)
• Discoverx (US)
• Proqinase GmbH (Germany)
• Marine Biological Laboratory (US)
• Biospherix (US)
• Essen Bioscience (US)
• Miltenyi Biotec (Switzerland)
• Bioagilytix Labs (US)
• Cell Biolabs (US)
• Biotek Instruments (US)
• Qgel SA (Switzerland)
• Enzo Life Sciences (Switzerland)
• Aurelia Bioscience (UK)
• Selexis SA (US)

Market segment by Type, the product can be split into

• Consumables
• Instruments
• Services
• Software

Market segment by Application, split into

• Pharmaceutical & Biotechnology Companies
• Academic & Government Institutions
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cell-based Assays status, future forecast, growth opportunity, key market and key players.
• To present the Cell-based Assays development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cell-based Assays are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cell-based Assays Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cell-based Assays Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Consumables
  1.4.3 Instruments
  1.4.4 Services
  1.4.5 Software
1.5 Market by Application
  1.5.1 Global Cell-based Assays Market Share by Application: 2020 VS 2026
  1.5.2 Pharmaceutical & Biotechnology Companies
  1.5.3 Academic & Government Institutions
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Cell-based Assays Industry Impact
  1.6.1 How the Covid-19 is Affecting the Cell-based Assays Industry
    1.6.1.1 Cell-based Assays Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Cell-based Assays Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Cell-based Assays Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cell-based Assays Market Perspective (2015-2026)
2.2 Cell-based Assays Growth Trends by Regions
  2.2.1 Cell-based Assays Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cell-based Assays Historic Market Share by Regions (2015-2020)
  2.2.3 Cell-based Assays Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cell-based Assays Market Growth Strategy
  2.3.6 Primary Interviews with Key Cell-based Assays Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cell-based Assays Players by Market Size
  3.1.1 Global Top Cell-based Assays Players by Revenue (2015-2020)
  3.1.2 Global Cell-based Assays Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cell-based Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cell-based Assays Market Concentration Ratio
  3.2.1 Global Cell-based Assays Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cell-based Assays Revenue in 2019
3.3 Cell-based Assays Key Players Head office and Area Served
3.4 Key Players Cell-based Assays Product Solution and Service
3.5 Date of Enter into Cell-based Assays Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cell-based Assays Historic Market Size by Type (2015-2020)
4.2 Global Cell-based Assays Forecasted Market Size by Type (2021-2026)

5 CELL-BASED ASSAYS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cell-based Assays Market Size by Application (2015-2020)
5.2 Global Cell-based Assays Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cell-based Assays Market Size (2015-2020)
6.2 Cell-based Assays Key Players in North America (2019-2020)
6.3 North America Cell-based Assays Market Size by Type (2015-2020)
6.4 North America Cell-based Assays Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cell-based Assays Market Size (2015-2020)
7.2 Cell-based Assays Key Players in Europe (2019-2020)
7.3 Europe Cell-based Assays Market Size by Type (2015-2020)
7.4 Europe Cell-based Assays Market Size by Application (2015-2020)

8 CHINA

8.1 China Cell-based Assays Market Size (2015-2020)
8.2 Cell-based Assays Key Players in China (2019-2020)
8.3 China Cell-based Assays Market Size by Type (2015-2020)
8.4 China Cell-based Assays Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cell-based Assays Market Size (2015-2020)
9.2 Cell-based Assays Key Players in Japan (2019-2020)
9.3 Japan Cell-based Assays Market Size by Type (2015-2020)
9.4 Japan Cell-based Assays Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cell-based Assays Market Size (2015-2020)
10.2 Cell-based Assays Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cell-based Assays Market Size by Type (2015-2020)
10.4 Southeast Asia Cell-based Assays Market Size by Application (2015-2020)

11 INDIA

11.1 India Cell-based Assays Market Size (2015-2020)
11.2 Cell-based Assays Key Players in India (2019-2020)
11.3 India Cell-based Assays Market Size by Type (2015-2020)
11.4 India Cell-based Assays Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cell-based Assays Market Size (2015-2020)
12.2 Cell-based Assays Key Players in Central & South America (2019-2020)
12.3 Central & South America Cell-based Assays Market Size by Type (2015-2020)
12.4 Central & South America Cell-based Assays Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 BD Medical (US)
  13.1.1 BD Medical (US) Company Details
  13.1.2 BD Medical (US) Business Overview and Its Total Revenue
  13.1.3 BD Medical (US) Cell-based Assays Introduction
  13.1.4 BD Medical (US) Revenue in Cell-based Assays Business (2015-2020))
  13.1.5 BD Medical (US) Recent Development
13.2 Danaher (US)
  13.2.1 Danaher (US) Company Details
  13.2.2 Danaher (US) Business Overview and Its Total Revenue
  13.2.3 Danaher (US) Cell-based Assays Introduction
  13.2.4 Danaher (US) Revenue in Cell-based Assays Business (2015-2020)
  13.2.5 Danaher (US) Recent Development
13.3 Thermo Fisher Scientific (US)
  13.3.1 Thermo Fisher Scientific (US) Company Details
  13.3.2 Thermo Fisher Scientific (US) Business Overview and Its Total Revenue
  13.3.3 Thermo Fisher Scientific (US) Cell-based Assays Introduction
  13.3.4 Thermo Fisher Scientific (US) Revenue in Cell-based Assays Business (2015-2020)
  13.3.5 Thermo Fisher Scientific (US) Recent Development
13.4 General Healthcare (UK)
  13.4.1 General Healthcare (UK) Company Details
  13.4.2 General Healthcare (UK) Business Overview and Its Total Revenue
  13.4.3 General Healthcare (UK) Cell-based Assays Introduction
  13.4.4 General Healthcare (UK) Revenue in Cell-based Assays Business (2015-2020)
  13.4.5 General Healthcare (UK) Recent Development
13.5 Merck KGaA (Germany)
  13.5.1 Merck KGaA (Germany) Company Details
  13.5.2 Merck KGaA (Germany) Business Overview and Its Total Revenue
  13.5.3 Merck KGaA (Germany) Cell-based Assays Introduction
  13.5.4 Merck KGaA (Germany) Revenue in Cell-based Assays Business (2015-2020)
  13.5.5 Merck KGaA (Germany) Recent Development
13.6 Perkinelmer (US)
  13.6.1 Perkinelmer (US) Company Details
  13.6.2 Perkinelmer (US) Business Overview and Its Total Revenue
  13.6.3 Perkinelmer (US) Cell-based Assays Introduction
  13.6.4 Perkinelmer (US) Revenue in Cell-based Assays Business (2015-2020)
  13.6.5 Perkinelmer (US) Recent Development
13.7 Charles River Laboratories (US)
  13.7.1 Charles River Laboratories (US) Company Details
  13.7.2 Charles River Laboratories (US) Business Overview and Its Total Revenue
  13.7.3 Charles River Laboratories (US) Cell-based Assays Introduction
  13.7.4 Charles River Laboratories (US) Revenue in Cell-based Assays Business (2015-2020)
  13.7.5 Charles River Laboratories (US) Recent Development
13.8 Life Technologies (US)
  13.8.1 Life Technologies (US) Company Details
  13.8.2 Life Technologies (US) Business Overview and Its Total Revenue
  13.8.3 Life Technologies (US) Cell-based Assays Introduction
  13.8.4 Life Technologies (US) Revenue in Cell-based Assays Business (2015-2020)
  13.8.5 Life Technologies (US) Recent Development
13.9 Lonza Group (Switzerland)
  13.9.1 Lonza Group (Switzerland) Company Details
  13.9.2 Lonza Group (Switzerland) Business Overview and Its Total Revenue
  13.9.3 Lonza Group (Switzerland) Cell-based Assays Introduction
  13.9.4 Lonza Group (Switzerland) Revenue in Cell-based Assays Business (2015-2020)
  13.9.5 Lonza Group (Switzerland) Recent Development
13.10 Cell Signaling Technology (US)
  13.10.1 Cell Signaling Technology (US) Company Details
  13.10.2 Cell Signaling Technology (US) Business Overview and Its Total Revenue
  13.10.3 Cell Signaling Technology (US) Cell-based Assays Introduction
  13.10.4 Cell Signaling Technology (US) Revenue in Cell-based Assays Business (2015-2020)
  13.10.5 Cell Signaling Technology (US) Recent Development
13.11 Promega (US)
  10.11.1 Promega (US) Company Details
  10.11.2 Promega (US) Business Overview and Its Total Revenue
  10.11.3 Promega (US) Cell-based Assays Introduction
  10.11.4 Promega (US) Revenue in Cell-based Assays Business (2015-2020)
  10.11.5 Promega (US) Recent Development
13.12 Cisbio Bioassays (France)
  10.12.1 Cisbio Bioassays (France) Company Details
  10.12.2 Cisbio Bioassays (France) Business Overview and Its Total Revenue
  10.12.3 Cisbio Bioassays (France) Cell-based Assays Introduction
  10.12.4 Cisbio Bioassays (France) Revenue in Cell-based Assays Business (2015-2020)
  10.12.5 Cisbio Bioassays (France) Recent Development
13.13 Discoverx (US)
  10.13.1 Discoverx (US) Company Details
  10.13.2 Discoverx (US) Business Overview and Its Total Revenue
  10.13.3 Discoverx (US) Cell-based Assays Introduction
  10.13.4 Discoverx (US) Revenue in Cell-based Assays Business (2015-2020)
  10.13.5 Discoverx (US) Recent Development
13.14 Proqinase GmbH (Germany)
  10.14.1 Proqinase GmbH (Germany) Company Details
  10.14.2 Proqinase GmbH (Germany) Business Overview and Its Total Revenue
  10.14.3 Proqinase GmbH (Germany) Cell-based Assays Introduction
  10.14.4 Proqinase GmbH (Germany) Revenue in Cell-based Assays Business (2015-2020)
  10.14.5 Proqinase GmbH (Germany) Recent Development
13.15 Marine Biological Laboratory (US)
  10.15.1 Marine Biological Laboratory (US) Company Details
  10.15.2 Marine Biological Laboratory (US) Business Overview and Its Total Revenue
  10.15.3 Marine Biological Laboratory (US) Cell-based Assays Introduction
  10.15.4 Marine Biological Laboratory (US) Revenue in Cell-based Assays Business (2015-2020)
  10.15.5 Marine Biological Laboratory (US) Recent Development
13.16 Biospherix (US)
  10.16.1 Biospherix (US) Company Details
  10.16.2 Biospherix (US) Business Overview and Its Total Revenue
  10.16.3 Biospherix (US) Cell-based Assays Introduction
  10.16.4 Biospherix (US) Revenue in Cell-based Assays Business (2015-2020)
  10.16.5 Biospherix (US) Recent Development
13.17 Essen Bioscience (US)
  10.17.1 Essen Bioscience (US) Company Details
  10.17.2 Essen Bioscience (US) Business Overview and Its Total Revenue
  10.17.3 Essen Bioscience (US) Cell-based Assays Introduction
  10.17.4 Essen Bioscience (US) Revenue in Cell-based Assays Business (2015-2020)
  10.17.5 Essen Bioscience (US) Recent Development
13.18 Miltenyi Biotec (Switzerland)
  10.18.1 Miltenyi Biotec (Switzerland) Company Details
  10.18.2 Miltenyi Biotec (Switzerland) Business Overview and Its Total Revenue
  10.18.3 Miltenyi Biotec (Switzerland) Cell-based Assays Introduction
  10.18.4 Miltenyi Biotec (Switzerland) Revenue in Cell-based Assays Business (2015-2020)
  10.18.5 Miltenyi Biotec (Switzerland) Recent Development
13.19 Bioagilytix Labs (US)
  10.19.1 Bioagilytix Labs (US) Company Details
  10.19.2 Bioagilytix Labs (US) Business Overview and Its Total Revenue
  10.19.3 Bioagilytix Labs (US) Cell-based Assays Introduction
  10.19.4 Bioagilytix Labs (US) Revenue in Cell-based Assays Business (2015-2020)
  10.19.5 Bioagilytix Labs (US) Recent Development
13.20 Cell Biolabs (US)
  10.20.1 Cell Biolabs (US) Company Details
  10.20.2 Cell Biolabs (US) Business Overview and Its Total Revenue
  10.20.3 Cell Biolabs (US) Cell-based Assays Introduction
  10.20.4 Cell Biolabs (US) Revenue in Cell-based Assays Business (2015-2020)
  10.20.5 Cell Biolabs (US) Recent Development
13.21 Biotek Instruments (US)
  10.21.1 Biotek Instruments (US) Company Details
  10.21.2 Biotek Instruments (US) Business Overview and Its Total Revenue
  10.21.3 Biotek Instruments (US) Cell-based Assays Introduction
  10.21.4 Biotek Instruments (US) Revenue in Cell-based Assays Business (2015-2020)
  10.21.5 Biotek Instruments (US) Recent Development
13.22 Qgel SA (Switzerland)
  10.22.1 Qgel SA (Switzerland) Company Details
  10.22.2 Qgel SA (Switzerland) Business Overview and Its Total Revenue
  10.22.3 Qgel SA (Switzerland) Cell-based Assays Introduction
  10.22.4 Qgel SA (Switzerland) Revenue in Cell-based Assays Business (2015-2020)
  10.22.5 Qgel SA (Switzerland) Recent Development
13.23 Enzo Life Sciences (Switzerland)
  10.23.1 Enzo Life Sciences (Switzerland) Company Details
  10.23.2 Enzo Life Sciences (Switzerland) Business Overview and Its Total Revenue
  10.23.3 Enzo Life Sciences (Switzerland) Cell-based Assays Introduction
  10.23.4 Enzo Life Sciences (Switzerland) Revenue in Cell-based Assays Business (2015-2020)
  10.23.5 Enzo Life Sciences (Switzerland) Recent Development
13.24 Aurelia Bioscience (UK)
  10.24.1 Aurelia Bioscience (UK) Company Details
  10.24.2 Aurelia Bioscience (UK) Business Overview and Its Total Revenue
  10.24.3 Aurelia Bioscience (UK) Cell-based Assays Introduction
  10.24.4 Aurelia Bioscience (UK) Revenue in Cell-based Assays Business (2015-2020)
  10.24.5 Aurelia Bioscience (UK) Recent Development
13.25 Selexis SA (US)
  10.25.1 Selexis SA (US) Company Details
  10.25.2 Selexis SA (US) Business Overview and Its Total Revenue
  10.25.3 Selexis SA (US) Cell-based Assays Introduction
  10.25.4 Selexis SA (US) Revenue in Cell-based Assays Business (2015-2020)
  10.25.5 Selexis SA (US) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cell-based Assays Key Market Segments
Table 2. Key Players Covered: Ranking by Cell-based Assays Revenue
Table 3. Ranking of Global Top Cell-based Assays Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cell-based Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Consumables
Table 6. Key Players of Instruments
Table 7. Key Players of Services
Table 8. Key Players of Software
Table 9. COVID-19 Impact Global Market: (Four Cell-based Assays Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Cell-based Assays Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Cell-based Assays Players to Combat Covid-19 Impact
Table 14. Global Cell-based Assays Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Cell-based Assays Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Cell-based Assays Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Cell-based Assays Market Share by Regions (2015-2020)
Table 18. Global Cell-based Assays Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Cell-based Assays Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Cell-based Assays Market Growth Strategy
Table 24. Main Points Interviewed from Key Cell-based Assays Players
Table 25. Global Cell-based Assays Revenue by Players (2015-2020) (Million US$)
Table 26. Global Cell-based Assays Market Share by Players (2015-2020)
Table 27. Global Top Cell-based Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-based Assays as of 2019)
Table 28. Global Cell-based Assays by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Cell-based Assays Product Solution and Service
Table 31. Date of Enter into Cell-based Assays Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Cell-based Assays Market Size by Type (2015-2020) (Million US$)
Table 34. Global Cell-based Assays Market Size Share by Type (2015-2020)
Table 35. Global Cell-based Assays Revenue Market Share by Type (2021-2026)
Table 36. Global Cell-based Assays Market Size Share by Application (2015-2020)
Table 37. Global Cell-based Assays Market Size by Application (2015-2020) (Million US$)
Table 38. Global Cell-based Assays Market Size Share by Application (2021-2026)
Table 39. North America Key Players Cell-based Assays Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Cell-based Assays Market Share (2019-2020)
Table 41. North America Cell-based Assays Market Size by Type (2015-2020) (Million US$)
Table 42. North America Cell-based Assays Market Share by Type (2015-2020)
Table 43. North America Cell-based Assays Market Size by Application (2015-2020) (Million US$)
Table 44. North America Cell-based Assays Market Share by Application (2015-2020)
Table 45. Europe Key Players Cell-based Assays Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Cell-based Assays Market Share (2019-2020)
Table 47. Europe Cell-based Assays Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Cell-based Assays Market Share by Type (2015-2020)
Table 49. Europe Cell-based Assays Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Cell-based Assays Market Share by Application (2015-2020)
Table 51. China Key Players Cell-based Assays Revenue (2019-2020) (Million US$)
Table 52. China Key Players Cell-based Assays Market Share (2019-2020)
Table 53. China Cell-based Assays Market Size by Type (2015-2020) (Million US$)
Table 54. China Cell-based Assays Market Share by Type (2015-2020)
Table 55. China Cell-based Assays Market Size by Application (2015-2020) (Million US$)
Table 56. China Cell-based Assays Market Share by Application (2015-2020)
Table 57. Japan Key Players Cell-based Assays Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Cell-based Assays Market Share (2019-2020)
Table 59. Japan Cell-based Assays Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Cell-based Assays Market Share by Type (2015-2020)
Table 61. Japan Cell-based Assays Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Cell-based Assays Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Cell-based Assays Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Cell-based Assays Market Share (2019-2020)
Table 65. Southeast Asia Cell-based Assays Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Cell-based Assays Market Share by Type (2015-2020)
Table 67. Southeast Asia Cell-based Assays Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Cell-based Assays Market Share by Application (2015-2020)
Table 69. India Key Players Cell-based Assays Revenue (2019-2020) (Million US$)
Table 70. India Key Players Cell-based Assays Market Share (2019-2020)
Table 71. India Cell-based Assays Market Size by Type (2015-2020) (Million US$)
Table 72. India Cell-based Assays Market Share by Type (2015-2020)
Table 73. India Cell-based Assays Market Size by Application (2015-2020) (Million US$)
Table 74. India Cell-based Assays Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Cell-based Assays Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Cell-based Assays Market Share (2019-2020)
Table 77. Central & South America Cell-based Assays Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Cell-based Assays Market Share by Type (2015-2020)
Table 79. Central & South America Cell-based Assays Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Cell-based Assays Market Share by Application (2015-2020)
Table 81. BD Medical (US) Company Details
Table 82. BD Medical (US) Business Overview
Table 83. BD Medical (US) Product
Table 84. BD Medical (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 85. BD Medical (US) Recent Development
Table 86. Danaher (US) Company Details
Table 87. Danaher (US) Business Overview
Table 88. Danaher (US) Product
Table 89. Danaher (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 90. Danaher (US) Recent Development
Table 91. Thermo Fisher Scientific (US) Company Details
Table 92. Thermo Fisher Scientific (US) Business Overview
Table 93. Thermo Fisher Scientific (US) Product
Table 94. Thermo Fisher Scientific (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 95. Thermo Fisher Scientific (US) Recent Development
Table 96. General Healthcare (UK) Company Details
Table 97. General Healthcare (UK) Business Overview
Table 98. General Healthcare (UK) Product
Table 99. General Healthcare (UK) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 100. General Healthcare (UK) Recent Development
Table 101. Merck KGaA (Germany) Company Details
Table 102. Merck KGaA (Germany) Business Overview
Table 103. Merck KGaA (Germany) Product
Table 104. Merck KGaA (Germany) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 105. Merck KGaA (Germany) Recent Development
Table 106. Perkinelmer (US) Company Details
Table 107. Perkinelmer (US) Business Overview
Table 108. Perkinelmer (US) Product
Table 109. Perkinelmer (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 110. Perkinelmer (US) Recent Development
Table 111. Charles River Laboratories (US) Company Details
Table 112. Charles River Laboratories (US) Business Overview
Table 113. Charles River Laboratories (US) Product
Table 114. Charles River Laboratories (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 115. Charles River Laboratories (US) Recent Development
Table 116. Life Technologies (US) Business Overview
Table 117. Life Technologies (US) Product
Table 118. Life Technologies (US) Company Details
Table 119. Life Technologies (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 120. Life Technologies (US) Recent Development
Table 121. Lonza Group (Switzerland) Company Details
Table 122. Lonza Group (Switzerland) Business Overview
Table 123. Lonza Group (Switzerland) Product
Table 124. Lonza Group (Switzerland) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 125. Lonza Group (Switzerland) Recent Development
Table 126. Cell Signaling Technology (US) Company Details
Table 127. Cell Signaling Technology (US) Business Overview
Table 128. Cell Signaling Technology (US) Product
Table 129. Cell Signaling Technology (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 130. Cell Signaling Technology (US) Recent Development
Table 131. Promega (US) Company Details
Table 132. Promega (US) Business Overview
Table 133. Promega (US) Product
Table 134. Promega (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 135. Promega (US) Recent Development
Table 136. Cisbio Bioassays (France) Company Details
Table 137. Cisbio Bioassays (France) Business Overview
Table 138. Cisbio Bioassays (France) Product
Table 139. Cisbio Bioassays (France) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 140. Cisbio Bioassays (France) Recent Development
Table 141. Discoverx (US) Company Details
Table 142. Discoverx (US) Business Overview
Table 143. Discoverx (US) Product
Table 144. Discoverx (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 145. Discoverx (US) Recent Development
Table 146. Proqinase GmbH (Germany) Company Details
Table 147. Proqinase GmbH (Germany) Business Overview
Table 148. Proqinase GmbH (Germany) Product
Table 149. Proqinase GmbH (Germany) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 150. Proqinase GmbH (Germany) Recent Development
Table 151. Marine Biological Laboratory (US) Company Details
Table 152. Marine Biological Laboratory (US) Business Overview
Table 153. Marine Biological Laboratory (US) Product
Table 154. Marine Biological Laboratory (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 155. Marine Biological Laboratory (US) Recent Development
Table 156. Biospherix (US) Company Details
Table 157. Biospherix (US) Business Overview
Table 158. Biospherix (US) Product
Table 159. Biospherix (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 160. Biospherix (US) Recent Development
Table 161. Essen Bioscience (US) Company Details
Table 162. Essen Bioscience (US) Business Overview
Table 163. Essen Bioscience (US) Product
Table 164. Essen Bioscience (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 165. Essen Bioscience (US) Recent Development
Table 166. Miltenyi Biotec (Switzerland) Company Details
Table 167. Miltenyi Biotec (Switzerland) Business Overview
Table 168. Miltenyi Biotec (Switzerland) Product
Table 169. Miltenyi Biotec (Switzerland) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 170. Miltenyi Biotec (Switzerland) Recent Development
Table 171. Bioagilytix Labs (US) Company Details
Table 172. Bioagilytix Labs (US) Business Overview
Table 173. Bioagilytix Labs (US) Product
Table 174. Bioagilytix Labs (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 175. Bioagilytix Labs (US) Recent Development
Table 176. Cell Biolabs (US) Company Details
Table 177. Cell Biolabs (US) Business Overview
Table 178. Cell Biolabs (US) Product
Table 179. Cell Biolabs (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 180. Cell Biolabs (US) Recent Development
Table 181. Biotek Instruments (US) Company Details
Table 182. Biotek Instruments (US) Business Overview
Table 183. Biotek Instruments (US) Product
Table 184. Biotek Instruments (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 185. Biotek Instruments (US) Recent Development
Table 186. Qgel SA (Switzerland) Company Details
Table 187. Qgel SA (Switzerland) Business Overview
Table 188. Qgel SA (Switzerland) Product
Table 189. Qgel SA (Switzerland) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 190. Qgel SA (Switzerland) Recent Development
Table 191. Enzo Life Sciences (Switzerland) Company Details
Table 192. Enzo Life Sciences (Switzerland) Business Overview
Table 193. Enzo Life Sciences (Switzerland) Product
Table 194. Enzo Life Sciences (Switzerland) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 195. Enzo Life Sciences (Switzerland) Recent Development
Table 196. Aurelia Bioscience (UK) Company Details
Table 197. Aurelia Bioscience (UK) Business Overview
Table 198. Aurelia Bioscience (UK) Product
Table 199. Aurelia Bioscience (UK) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 200. Aurelia Bioscience (UK) Recent Development
Table 201. Selexis SA (US) Company Details
Table 202. Selexis SA (US) Business Overview
Table 203. Selexis SA (US) Product
Table 204. Selexis SA (US) Revenue in Cell-based Assays Business (2015-2020) (Million US$)
Table 205. Selexis SA (US) Recent Development
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cell-based Assays Market Share by Type: 2020 VS 2026
Figure 2. Consumables Features
Figure 3. Instruments Features
Figure 4. Services Features
Figure 5. Software Features
Figure 6. Global Cell-based Assays Market Share by Application: 2020 VS 2026
Figure 7. Pharmaceutical & Biotechnology Companies Case Studies
Figure 8. Academic & Government Institutions Case Studies
Figure 9. Other Case Studies
Figure 10. Cell-based Assays Report Years Considered
Figure 11. Global Cell-based Assays Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cell-based Assays Market Share by Regions: 2020 VS 2026
Figure 13. Global Cell-based Assays Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cell-based Assays Market Share by Players in 2019
Figure 16. Global Top Cell-based Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell-based Assays as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cell-based Assays Revenue in 2019
Figure 18. North America Cell-based Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cell-based Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cell-based Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cell-based Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cell-based Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cell-based Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cell-based Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. BD Medical (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BD Medical (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 27. Danaher (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Danaher (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 29. Thermo Fisher Scientific (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Thermo Fisher Scientific (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 31. General Healthcare (UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. General Healthcare (UK) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 33. Merck KGaA (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Merck KGaA (Germany) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 35. Perkinelmer (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Perkinelmer (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 37. Charles River Laboratories (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Charles River Laboratories (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 39. Life Technologies (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Life Technologies (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 41. Lonza Group (Switzerland) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Lonza Group (Switzerland) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 43. Cell Signaling Technology (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cell Signaling Technology (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 45. Promega (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Promega (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 47. Cisbio Bioassays (France) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Cisbio Bioassays (France) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 49. Discoverx (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Discoverx (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 51. Proqinase GmbH (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Proqinase GmbH (Germany) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 53. Marine Biological Laboratory (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Marine Biological Laboratory (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 55. Biospherix (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biospherix (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 57. Essen Bioscience (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Essen Bioscience (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 59. Miltenyi Biotec (Switzerland) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Miltenyi Biotec (Switzerland) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 61. Bioagilytix Labs (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Bioagilytix Labs (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 63. Cell Biolabs (US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Cell Biolabs (US) Revenue Growth Rate in Cell-based Assays Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed